David F Burgstahler
CIK 1374179 · President and CEO · last filed 2023-01-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$103.60M
Companies
11
Total Filings
41
Lifetime Open-Market Net
-$123.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc (RVLP) Delisted | Director | 0 | $0.03 | $0 | $12.40M | 2 | 2023-01-30 |
| OABIW | Director | 15,871,242 | $0.08 | $1.32M | $0 | 2 | 2023-01-05 |
| RVL Pharmaceuticals plc (OSMT) Delisted | Director | 15,730,864 | $1.11 | $17.46M | $6.25M | 2 | 2020-11-23 |
| ORGO | Director | 29,840,171 | $2.53 | $75.50M | $116.01M | 1 | 2020-11-19 |
| WideOpenWest, Inc. (WOW) Delisted | Director | 27,145,193 | $5.20 | $141.16M | $0 | 3 | 2019-05-13 |
| LNTH | Director | 260,501 | $102.64 | $26.74M | -$154.91M | 9 | 2017-09-11 |
| Organogenesis Holdings Inc. (AHPAW) Delisted | President and CEO | — | $0.69 | — | $0 | 1 | 2017-07-07 |
| INCR | Director | 42,406 | $0.92 | $39.0K | $43.2K | 4 | 2017-05-24 |
| ANGIODYNAMICS INC (ANGO.V) Delisted | Director | 1,470,401 | — | — | -$103.29M | 10 | 2017-04-14 |
| Organogenesis Holdings Inc. (AHPAU) Delisted | President and CEO | — | $6.16 | — | $0 | 1 | 2016-11-29 |
| Warner Chilcott plc (WCRX) Delisted | Director | 20,000 | — | — | $304.2K | 4 | 2009-08-07 |
Recent Filings · Page 2 of 5
41 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-15 | WideOpenWest, Inc. (WOW) Delisted | Grant (A) | +272,592 | $0 | EDGAR |
| 2018-01-10 | WideOpenWest, Inc. (WOW) Delisted | Other (J) | +35,387 | $0 | EDGAR |
| 2017-09-11 | LNTH | Sell (S) | −102,958 | -$1.70M | EDGAR |
| 2017-09-06 | LNTH | Sell (S) | −78,833 | -$1.34M | EDGAR |
| 2017-08-31 | LNTH | Sell (S) | −230,685 | -$3.98M | EDGAR |
| 2017-08-28 | LNTH | Sell (S) | −91,166 | -$1.55M | EDGAR |
| 2017-08-16 | LNTH | Mixed | −5,489,625 | -$94.42M | EDGAR |
| 2017-07-07 | Organogenesis Holdings Inc. (AHPAW) Delisted | Sell (S) | — | $0 | EDGAR |
| 2017-06-22 | LNTH | Sell (S) | −3,000,000 | -$44.61M | EDGAR |
| 2017-05-24 | INCR | Grant (A) | +2,693 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.